FDA Says Industry Has Work Left To Do To Make Antiviral Claims For Topicals
This article was originally published in The Rose Sheet
Executive Summary
FDA has rejected a citizen petition seeking antiviral labeling for OTC products covered by the Healthcare Antiseptic Drug Products monograph